Summary:
Chronic graft-versus-host disease (cGVHD) occurs in approximately 60–80% of those who survive over 100 days after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the pathophysiology of cGVHD is poorly understood. To gain more insight into the immunological mechanism of cGVHD, we examine cytokine production of peripheral blood T cells from 19 patients in the chronic phase of allo-HSCT. The percentage of IFN-γ-producing CD8+ T cells among CD8+ T cells was significantly higher in patients with or without cGVHD than in normal control subjects (P<0.001). On the other hand, the percentage of IL-4-producing CD8+ T cells among CD8+ T cells was significantly higher in patients with cGVHD (mean 3.3%; range 1.3–8.2%) than in patients without cGVHD (mean 1.2%; range 0.8–1.7%) and normal control subjects (mean 1.1%; range 0.1–1.6%) (both P<0.001). By contrast, the percentage of IL-4-producing CD4+ T cells was not different among patients with and without cGVHD and normal controls. These findings suggest that IL-4-producing CD8+ T cells may be an immunological marker of cGVHD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Storb R, Thomas ED . Graft-versus-host disease in dog and man: the Seattle experience. Immunol Rev 1985; 88: 215–238.
Roy J, McGlave PB, Filipovich AH et al. Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy. Bone Marrow Transplant 1992; 10: 77–82.
Atkinson K, Horowitz MM, Gale RP et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990; 75: 2459–2464.
Ochs LA, Miller WJ, Filipovich AH et al. Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation. Bone Marrow Transplant 1994; 13: 455–460.
Sutherland HJ, Fyles GM, Adams G et al. Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transplant 1997; 19: 1129–1136.
Syrjala KL, Chapko MK, Vitaliano PP et al. Recovery after allogeneic marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transplant 1993; 11: 319–327.
Duell T, van Lint MT, Ljungman P et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med 1997; 126: 184–192.
Sad S, Marcotte R, Mosmann TR . Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 1995; 2: 271–279.
Croft M, Carter L, Swain SL, Dutton RW . Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 1994; 180: 1715–1728.
Kayaba H, Hirokawa M, Watanabe A et al. Serum markers of graft-versus-host disease after bone marrow transplantation. J Allergy Clin Immunol 2000; 106: S40–S44.
Kami M, Matsumura T, Tanaka Y et al. Serum levels of soluble interleukin-2 receptor after bone marrow transplantation: a true marker of acute graft-versus-host disease. Leuk Lymphoma 2000; 38: 533–540.
Abdallah AN, Boiron JM, Attia Y et al. Plasma cytokines in graft vs host disease and complications following bone marrow transplantation. Hematol Cell Ther 1997; 39: 27–32.
Miyamoto T, Akashi K, Hayashi S et al. Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease. Bone Marrow Transplant 1996; 17: 185–190.
Imamura M, Hashino S, Kobayashi H et al. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease. Bone Marrow Transplant 1994; 13: 745–751.
Nakamura H, Komatsu K, Ayaki M et al. Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation. J Allergy Clin Immunol 2000; 106: S45–50.
Niederwieser D, Herold M, Woloszczuk W et al. Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation 1990; 50: 620–625.
Min CK, Lee WY, Min DJ et al. The kinetics of circulating cytokines including IL-6, TNF-alpha, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 935–940.
Symington FW, Symington BE, Liu PY et al. The relationship of serum IL-6 levels to acute graft-versus-host disease and hepatorenal disease after human bone marrow transplantation. Transplantation 1992; 54: 457–462.
Ferrara JL . Cytokine dysregulation as a mechanism of graft versus host disease. Curr Opin Immunol 1993; 5: 794–799.
Fallen PR, McGreavey L, Madrigal JA et al. Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant 2003; 32: 1001–1014.
Tanaka J, Imamura M, Kasai M et al. The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease. Bone Marrow Transplant 1997; 19: 571–576.
Allen RD, Staley TA, Sidman CL . Differential cytokine expression in acute and chronic graft-versus-host-disease. Eur J Immunol 1993; 23: 333–337.
Foss FM, Gorgun G, Miller KB . Extracorporeal photopheresis in chronic graft-versus-host disease. Bone Marrow Transplant 2002; 29: 719–725.
Korholz D, Kunst D, Hempel L et al. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 691–695.
Barak V, Levi-Schaffer F, Nisman B, Nagler A . Cytokine dysregulation in chronic graft-versus-host Disease. Leuk Lymphoma 1995; 17: 169–173.
Liem LM, van Houwelingen HC, Goulmy E . Serum cytokine levels after HLA-identical bone marrow transplantation. Transplantation 1998; 66: 863–871.
Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.
Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.
Hamann D, Baars PA, Rep MH et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997; 186: 1407–1418.
Milica V-S, Beejal V, Patricia G-S et al. Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes. Blood 2000; 95: 231–240.
Le Gros G, Erard F . Non-cytotoxic, IL-4, IL-5, IL-10 producing CD8+ T cells: their activation and effector functions. Curr Opin Immunol 1994; 6: 453–457.
Cronin Jr DC, Stack R, Fitch FW . IL-4-producing CD8+ T cell clones can provide B cell help. J Immunol 1995; 154: 118–127.
De Wit D, van Mechelen M, Zanin C et al. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J Immunol 1993; 150: 361–366.
Garlisi CG, Pennline KJ, Smith SR et al. Cytokine gene expression in mice undergoing chronic graft-versus-host disease. Mol Immunol 1993; 30: 669–677.
Umland SP, Razac S, Nahrebne DK, Seymour BW . Effects of in vivo administration of interferon (IFN)-gamma, anti-IFN-gamma, or anti-interleukin-4 monoclonal antibodies in chronic autoimmune graft-versus-host disease. Clin Immunol Immunopathol 1992; 63: 66–73.
Acknowledgements
We thank Professor Seizaburo Arita of Kansai Medical University for the evaluation of statistical analyses. We also thank Miss Tomoko Masuda for her secretarial work and assistance in experiments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakamura, K., Amakawa, R., Takebayashi, M. et al. IL-4-producing CD8+ T cells may be an immunological hallmark of chronic GVHD. Bone Marrow Transplant 36, 639–647 (2005). https://doi.org/10.1038/sj.bmt.1705107
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705107
Keywords
This article is cited by
-
Novel biomanufacturing platform for large-scale and high-quality human T cells production
Journal of Biological Engineering (2019)
-
Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Annals of Hematology (2015)